News Merck to file for new use for antibiotic Zerbaxa Antibiotic matched standard of care in phase 3 trial
Partner Content Partner Content SMi’s Exclusive Interview with MedImmune Principal Scientist... An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released
News Novartis to cease antibiotic R&D despite superbug threat Yet another big pharma quits antibiotics research
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
News Cut use of antibiotics in nursing homes, pharmacists say Pharmacists could train staff to cut prescriptions
Partner Content Partner Content Ground-breaking research in continuous fight against AMR The BBC recently reported on US's scientists discovery of a new family of antibiotics in soil samples.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.